REIMBURSEMENT

TASK FORCE

 

 

Overview

 

The purpose of the Digital Pathology Association Reimbursement Task Force is to support the market access of digital pathology solutions globally and drive the value of whole slide imaging (WSI) and AI-based algorithms. The key objectives of the task force are:

  • Drive and shape the model for reimbursement for WSI and AI-based image analysis
  • Support increased market access for DP solutions globally
  • Be the trusted resource (single point of contact) for reimbursement/market access issues for digital pathology
  • Create uniformity in communication around reimbursement for digital pathology solutions
  • Map the reimbursement environment globally and set the strategy for DPA influence

Participation in this Task Force is open to Benefactor member representatives only.


Committee Members

 

Chair: Michael Rivers & Dr. Paul Gerrard

 

  • James Almas, LabCorp
  • Jennifer Archer, MPP, Artera
  • Jorge Belmonte, Hologic, Inc.
  • Scott Blakely, Hamamatsu Corporation
  • Nick Brown, PathAI
  • Nathan Buchbinder, Proscia Inc.
  • Joseph Chiweshe, MD MPH, Leica Biosystems
  • Dana Dilbeck, Agilent Technologies
  • Chris Garcia, MD, Mayo Clinic
  • Paul Gerrard, PathAI
  • Ben Glass, PathAI
  • Nicholas Halzack, Roche
  • Raymond Jenoski, MS, Hologic, Inc.
  • David Klimstra, MD, Paige
  • Giovanni Lujan, MD, Ohio State University Wexner Medical Center
  • Anil Parwani, MD, PhD, MBA, Ohio State University Wexner Medical Center
  • Michael Rivers, Roche
  • Jennifer Samboy, MHA, Philips
  • Elizabeth Sheppard, HT(ASCP), MBA, AstraZeneca
  • Timothy Showalter, Artera
  • Rajendra Singh, MD, Summit Health
  • Jay Tolley, Mayo Clinic Platform
  • Thomas Westerling-Bui, PhD, Aiforia